
seres
SERES incorporates the spirit of exploration into a new global journey by introducing its products, redefining luxury with intelligence.
About Us - Seres Therapeutics
Seres’ visionary team has been at the forefront of microbiome therapeutics for over a decade. Discover our mission, leadership, partners, and more.
Seres Auto - Wikipedia
Seres is a brand of electric vehicles marketed by Seres Group. Since 2023, Seres brand has shifted to export-focus brand, while AITO and Landian became a domestic-only brand.
SERES - SERES Group
Feb 1, 2026 · SERES is a technology-based manufacturing enterprise with new energy vehicles as its core business. The business area of SERES covers R&D, manufacturing, sales & services of NEVs, …
Seres to lay off 30% of employees, pause lead program
Feb 12, 2026 · Just months after laying off a quarter of its workforce to fund a phase 2 study of its bloodstream infection preventive treatment, Seres Therapeutics is pausing that investment and …
Seres – EV, Motor
SF Motors, Inc., dba SERES, is a customer-oriented E-Powertrain technology development & manufacturing company. We drive the automotive energy iteration. We are a Silicon Valley-based …
Seres Therapeutics Announces Appointment of Richard N. Kender as ...
Mar 2, 2026 · Seres is implementing a focused corporate strategy to advance live biotherapeutic programs in inflammatory and immune diseases and support the readout of investigator-sponsored …
SERES: Electric Cars - EV Database
3 days ago · SERES: Pioneering Electric Vehicle Manufacturing. SERES, a renowned Chinese electric vehicle brand, is revolutionizing the automotive industry with its commitment to new energy electric …
First Look Review: The Seres 5 is an interesting mid-size SUV
Jun 1, 2024 · Chinese auto brand Seres (you’d recall SF Motors, based in California, which it was known earlier as) has begun introducing electric models worldwide. This year, the company plans to …
Seres to lay off staff, pause top program in latest reboot
Feb 12, 2026 · Seres Therapeutics, a cash-strapped developer of microbiome drugs, will cut staff and pause its lead program as part of a reboot that’ll see the company focus resources on earlier …